Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,506.48
(
-1.51%
)
US TECH 100
23,484.80
(
-0.99%
)
Dow Jones
45,577.47
(
-0.96%
)
Brent Oil
105.10
(
-1.72%
)
Bitcoin
70,439.01
(
-0.11%
)
News Focus
News Focus
Post# of 257268
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

NP1986

Send PM Follow Ignore
Followers 6
Posts 541
Boards Moderated 0
Alias Born 06/07/2011

NP1986

Re: biomaven0 post# 148069

Sunday, 09/02/2012 3:41:20 AM

Sunday, September 02, 2012 3:41:20 AM

Post# of 257268
I initiated a small position in MDVN on Friday after the trading halt. I'm obviously late to the party, but I agree that this is a solid drug for prostate cancer and don't think the company is overvalued. IMO, Zytiga's sales so far have been pretty remarkable, and that ought to bode well for enzalutamide.

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today